The R21/Matrix-M malaria vaccine: questions remain - Author's reply.
Saved in:
| Title: | The R21/Matrix-M malaria vaccine: questions remain - Author's reply. |
|---|---|
| Authors: | Datoo MS; University of Oxford, Oxford OX1 2JD, UK. Electronic address: mehreen.datoo@ndm.ox.ac.uk., Hill AVS; University of Oxford, Oxford OX1 2JD, UK., Beaumont E; London School of Hygiene & Tropical Medicine, London, UK., Bradley J; London School of Hygiene & Tropical Medicine, London, UK. |
| Source: | Lancet (London, England) [Lancet] 2025 Jan 25; Vol. 405 (10475), pp. 299-301. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39863365 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The R21/Matrix-M malaria vaccine: questions remain - Author's reply. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Datoo+MS%22">Datoo MS</searchLink>; University of Oxford, Oxford OX1 2JD, UK. Electronic address: mehreen.datoo@ndm.ox.ac.uk.<br /><searchLink fieldCode="AU" term="%22Hill+AVS%22">Hill AVS</searchLink>; University of Oxford, Oxford OX1 2JD, UK.<br /><searchLink fieldCode="AU" term="%22Beaumont+E%22">Beaumont E</searchLink>; London School of Hygiene & Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Bradley+J%22">Bradley J</searchLink>; London School of Hygiene & Tropical Medicine, London, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2025 Jan 25; Vol. 405 (10475), pp. 299-301. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39863365 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0140-6736(24)02780-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 299 Titles: – TitleFull: The R21/Matrix-M malaria vaccine: questions remain - Author's reply. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Datoo MS – PersonEntity: Name: NameFull: Hill AVS – PersonEntity: Name: NameFull: Beaumont E – PersonEntity: Name: NameFull: Bradley J IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 01 Text: 2025 Jan 25 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1474-547X Numbering: – Type: volume Value: 405 – Type: issue Value: 10475 Titles: – TitleFull: Lancet (London, England) Type: main |
| ResultId | 1 |